Researchers identify gene variant that protects against Alzheimer's disease

November 30, 2017
PET scan of a human brain with Alzheimer's disease. Credit: public domain

Research published Wednesday in Genome Medicine details a novel and promising approach in the effort to treat Alzheimer's disease.

Brigham Young University professors Perry Ridge and John Kauwe led the discovery of a rare genetic that provides a protective effect for high-risk individuals—elderly people who carry known for Alzheimer's— who never acquired the .

In other words, there's a specific reason why people who should get Alzheimer's remain healthy. Study authors believe this genetic function could be targeted with drugs to help reduce the risk of people getting the disease.

"Instead of identifying genetic variants that are causing disease, we wanted to identify genetic variants that are protecting people from developing disease," said Ridge, assistant professor of biology at BYU. "And we were able to identify a promising genetic variant."

That former approach to Alzheimer's disease has been generally effective in producing a list of genes that might impact risk for the disease, but it leaves researchers without sufficient data on what to do next. In this new approach, Ridge and Kauwe develop the biological mechanism by which a genetic variant actually impacts Alzheimer's disease.

Using data from the Utah Population Database—a 20-million-record database of the LDS Church's genealogical records combined with historical medical records from Utah—Ridge and Kauwe first identified families that had a large number of resilient individuals: those who carried the main genetic risk factor for Alzheimer's (E4 Allele) but remained healthy into advanced age.

Using whole genome sequencing and a linkage analysis methodology, they then looked for the DNA that those resilient individuals shared with each other that they didn't share with loved ones who died of Alzheimer's. They discovered the resilient subjects shared a variant in the RAB10 gene while those who got the disease did not share the genetic variant.

Once the researchers identified the potentially protective gene variant, they over expressed it in cells and under expressed it in cells to see the impact on Alzheimer's disease related proteins. They learned that when this gene is reduced in your body, it has the potential to reduce your risk for Alzheimer's.

"There are currently no meaningful interventions for Alzheimer disease; No prevention, no modifying therapies, no cure," Kauwe said. "The discoveries we're reporting in this manuscript provide a new target with a new mechanism that we believe has great potential to impact Alzheimer's disease in the future."

Explore further: Multi-gene test predicts Alzheimer's better than APOE E4 alone

More information: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience, Genome Medicine (2017). DOI: 10.1186/s13073-017-0486-1

Related Stories

Multi-gene test predicts Alzheimer's better than APOE E4 alone

September 22, 2017
A new test that combines the effects of more than two dozen genetic variants, most associated by themselves with only a small risk of Alzheimer's disease, does a better job of predicting which cognitively normal older adults ...

Newly identified rare Alzheimer's disease gene mutation more common in Icelandic people

October 20, 2016
People with Icelandic heritage are more likely to carry a novel rare mutation in the TM2D3 gene, which leads to greater risk for Alzheimer's disease, based on a new study published October 14th, 2016 in PLOS Genetics by Johanna ...

Gene variant protecting against Alzheimer's disease decreases plasma beta-amyloid levels

June 20, 2017
New research from the University of Eastern Finland shows that the APP gene variant protecting against Alzheimer's disease significantly decreases plasma beta-amyloid levels in a population cohort. This is a very significant ...

Genetic and non-genetic resilience against memory decline and Alzheimer's

July 25, 2016
Researchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer's, while others don't. At AAIC2016, two teams of researchers are presenting findings revealing clues ...

Study finds Alzheimer's disease likely not caused by low body mass index

May 9, 2017
A new large-scale genetic study found that low body mass index (BMI) is likely not a causal risk factor for Alzheimer's disease, as earlier research had suggested, according to a study published in the Endocrine Society's ...

Two new genes linked to Alzheimer's risk

July 18, 2017
A team of researchers led by Cardiff University has identified two genes that influence a person's risk of developing Alzheimer's disease.

Recommended for you

Major cause of dementia discovered

December 11, 2017
An international team of scientists have confirmed the discovery of a major cause of dementia, with important implications for possible treatment and diagnosis.

Canola oil linked to worsened memory and learning ability in Alzheimer's

December 7, 2017
Canola oil is one of the most widely consumed vegetable oils in the world, yet surprisingly little is known about its effects on health. Now, a new study published online December 7 in the journal Scientific Reports by researchers ...

Genetics study suggests that education reduces risk of Alzheimer's disease

December 7, 2017
The theory that education protects against Alzheimer's disease has been given further weight by new research from the University of Cambridge, funded by the European Union. The study is published today in the BMJ.

Healthy mitochondria could stop Alzheimer's

December 6, 2017
Alzheimer's disease is the most common form of dementia and neurodegeneration worldwide. A major hallmark of the disease is the accumulation of toxic plaques in the brain, formed by the abnormal aggregation of a protein called ...

Alzheimer's damage in mice reduced with compound that targets APOE gene

December 6, 2017
People who carry the APOE4 genetic variant face a substantial risk for developing Alzheimer's disease.

Lithium in water associated with slower rate of Alzheimer's disease deaths

December 5, 2017
Rates of diabetes and obesity, which are important risk factors for Alzheimer's disease, also decrease if there is a particular amount of lithium in the water, says the study, published recently in the Journal of Alzheimer's ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.